I am dedicated to the shaping, the advancement and the clinical translation of the new scientific and technological discipline of in silico medicine and in particular in silico oncology. The proposed notion and system of the virtual twin "Oncosimulator", aiming at individualized treatment optimization and the conduction of in silico clinical research via multiscale mechanistic modelling, artificial intelligence, biostatistics and software engineering is the focus of my group's research.